Rheumatoid Arthritis & DMARDs
Drugs that change the disease, not just the pain — methotrexate, and the biologic and targeted DMARDs.
Rheumatoid Arthritis: Changing the Disease, Not Just the Pain
Painkillers can ease the ache of rheumatoid arthritis, but they don't stop the disease from destroying joints. The breakthrough was a completely different class of drug — the DMARDs — that actually slows or halts the underlying process. Understanding the difference between relieving symptoms and modifying disease is the key to all of rheumatology.
Methotrexate: The Once-a-Week Drug That Anchors Rheumatology
Methotrexate is the single most important drug in rheumatology — the first-line, 'anchor' DMARD for rheumatoid arthritis. It also carries one of medicine's most dangerous dosing traps: it's taken ONCE A WEEK, and confusing that for a daily dose has killed people. Understanding this one drug well is genuinely life-and-death knowledge.
Biologic & Targeted DMARDs: Precision Weapons for Rheumatoid Arthritis
When methotrexate and the older DMARDs aren't enough, the biologics take over — the same precision-targeted antibodies you've now met in asthma, cystic fibrosis and inflammatory bowel disease, aimed here at the joints. By this point the pattern should feel familiar, and that familiarity is exactly the point.
